Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
=========================================================================================================


Rogiers A, Pires da Silva I, Tentori C, et al Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. *J Immunother Cancer* 2021;**9**:e001931.

The affiliation of author Paola Queirolo was incorrectly listed. The correct affiliation is:

Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

*   © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

[http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/).